• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Angiotensin-Converting Enzyme 2 as the Molecular Bridge Between Epidemiologic and Clinical Features of COVID-19.

作者信息

Bombardini Tonino, Picano Eugenio

机构信息

Consiglio Nazionale Ricerche - National Research Council, Institute of Clinical Physiology, Biomedicine Department, Pisa, Italy.

Consiglio Nazionale Ricerche - National Research Council, Institute of Clinical Physiology, Biomedicine Department, Pisa, Italy.

出版信息

Can J Cardiol. 2020 May;36(5):784.e1-784.e2. doi: 10.1016/j.cjca.2020.03.026. Epub 2020 Mar 29.

DOI:10.1016/j.cjca.2020.03.026
PMID:32299780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7118531/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87ac/7118531/93999ef9596f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87ac/7118531/93999ef9596f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87ac/7118531/93999ef9596f/gr1_lrg.jpg

相似文献

1
Angiotensin-Converting Enzyme 2 as the Molecular Bridge Between Epidemiologic and Clinical Features of COVID-19.血管紧张素转换酶2作为2019冠状病毒病流行病学与临床特征之间的分子桥梁
Can J Cardiol. 2020 May;36(5):784.e1-784.e2. doi: 10.1016/j.cjca.2020.03.026. Epub 2020 Mar 29.
2
COVID-19 and the cardiovascular system.新型冠状病毒肺炎与心血管系统。
Nat Rev Cardiol. 2020 May;17(5):259-260. doi: 10.1038/s41569-020-0360-5.
3
Coronavirus disease 2019 and the cardiovascular system: Impacts and implications.2019冠状病毒病与心血管系统：影响与启示。
Indian Heart J. 2020 Jan-Feb;72(1):1-6. doi: 10.1016/j.ihj.2020.03.006. Epub 2020 Apr 9.
4
Cardiovascular disease, heart failure and COVID-19.心血管疾病、心力衰竭与2019冠状病毒病
J Renin Angiotensin Aldosterone Syst. 2020 Apr-Jun;21(2):1470320320926903. doi: 10.1177/1470320320926903.
5
Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?2019冠状病毒病（COVID-19）：血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂是否具有双相效应？
J Am Heart Assoc. 2020 Apr 7;9(7):e016509. doi: 10.1161/JAHA.120.016509. Epub 2020 Apr 1.
6
Current data on the cardiovascular effects of COVID-19.关于新冠病毒病心血管影响的当前数据。
Hellenic J Cardiol. 2020 Jan-Feb;61(1):46-48. doi: 10.1016/j.hjc.2020.04.001. Epub 2020 Apr 18.
7
Taste and Smell Dysfunction in COVID-19 Patients.新冠病毒感染患者的味觉和嗅觉功能障碍
Ann Otol Rhinol Laryngol. 2020 Oct;129(10):1041-1042. doi: 10.1177/0003489420932617. Epub 2020 May 29.
8
Risk of COVID-19 for patients with obesity.肥胖患者感染新冠病毒的风险。
Obes Rev. 2020 Jun;21(6):e13034. doi: 10.1111/obr.13034. Epub 2020 Apr 13.
9
COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure.心力衰竭背景下COVID-19对肾素-血管紧张素系统的干扰
mBio. 2020 May 22;11(3):e00946-20. doi: 10.1128/mBio.00946-20.
10
Pain: A potential new label of COVID-19.疼痛：新冠病毒疾病的一个潜在新标识。
Brain Behav Immun. 2020 Jul;87:159-160. doi: 10.1016/j.bbi.2020.05.025. Epub 2020 May 7.

引用本文的文献

1
Immunomodulatory Effects of Vitamin D and Zinc on Viral Infection.维生素D和锌对病毒感染的免疫调节作用
Biol Trace Elem Res. 2025 Jan;203(1):1-17. doi: 10.1007/s12011-024-04139-y. Epub 2024 Mar 7.
2
Impact of vitamin D supplementation on the clinical outcomes of COVID-19 pneumonia patients: a single-center randomized controlled trial.维生素 D 补充对 COVID-19 肺炎患者临床结局的影响：一项单中心随机对照试验。
BMC Complement Med Ther. 2024 Feb 21;24(1):97. doi: 10.1186/s12906-024-04393-6.
3
Toll-like Receptor Mediation in SARS-CoV-2: A Therapeutic Approach.

本文引用的文献

1
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020.2019新型冠状病毒病（COVID-19）疫情的流行病学特征 - 中国，2020年
China CDC Wkly. 2020 Feb 21;2(8):113-122.
2
Angiotensin-converting enzyme 2 protects from severe acute lung failure.血管紧张素转换酶2可预防严重急性肺衰竭。
Nature. 2005 Jul 7;436(7047):112-6. doi: 10.1038/nature03712.
3
ACE and ACE2: a tale of two enzymes.血管紧张素转换酶与血管紧张素转换酶2：两种酶的故事。
Toll 样受体在 SARS-CoV-2 中的作用：一种治疗方法。
Int J Mol Sci. 2022 Sep 14;23(18):10716. doi: 10.3390/ijms231810716.
4
Development of Metal Complexes for Treatment of Coronaviruses.金属配合物治疗冠状病毒的研究进展。
Int J Mol Sci. 2022 Jun 8;23(12):6418. doi: 10.3390/ijms23126418.
5
COVID-19 Vaccines: Current and Future Perspectives.新冠疫苗：现状与未来展望
Vaccines (Basel). 2022 Apr 13;10(4):608. doi: 10.3390/vaccines10040608.
6
Causal Links between Hypovitaminosis D and Dysregulation of the T Cell Connection of Immunity Associated with Obesity and Concomitant Pathologies.维生素D缺乏与肥胖及相关合并症所伴免疫T细胞连接失调之间的因果联系
Biomedicines. 2021 Nov 23;9(12):1750. doi: 10.3390/biomedicines9121750.
7
Understanding the clinical utility of favipiravir (T-705) in coronavirus disease of 2019: a review.了解法匹拉韦（T-705）在2019年冠状病毒病中的临床应用：一项综述。
Ther Adv Infect Dis. 2021 Dec 4;8:20499361211063016. doi: 10.1177/20499361211063016. eCollection 2021 Jan-Dec.
8
COVID-19 associated collapsing glomerulopathy presenting as acute kidney injury on chronic kidney disease: a case report and review of the literature.COVID-19 相关的塌陷性肾小球病在慢性肾脏病基础上表现为急性肾损伤：病例报告及文献复习。
CEN Case Rep. 2022 May;11(2):273-277. doi: 10.1007/s13730-021-00667-x. Epub 2021 Nov 26.
9
Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients.从分子机制到治疗干预的肺纤维化：来自 COVID-19 后患者的经验教训。
Biochem Pharmacol. 2021 Nov;193:114812. doi: 10.1016/j.bcp.2021.114812. Epub 2021 Oct 21.
10
The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19.《再利用 ACE2 抑制剂：COVID-19 的 SARS-CoV-2 进入抑制剂》。
Top Curr Chem (Cham). 2021 Oct 8;379(6):40. doi: 10.1007/s41061-021-00353-7.
Eur Heart J. 2005 Feb;26(4):322-4. doi: 10.1093/eurheartj/ehi043. Epub 2005 Jan 25.